Recent estimates suggest that as many as 12 percent of Americans are now taking GLP-1s
GLP-1RAs affects the central nervous system, including reducing appetite, improving diet control, increasing satiety, reducing calorie intake, etc
Our team also includes registered dietitians who guide you in developing a realistic meal replacement and physical activity plan
One possible reason, investigators explained, is that these medications may affect blood flow or oxygen levels in the eye, which could also play a role in conditions such as nAMD
Oral GLP-1s (Lillys paltusotine-orforglipron, etc.) are expected in late 2025/2026, and might be covered differently (some plans treat orals less restrictively than injectables)
Some of the substances tested include alcohol, nicotine, cocaine, and opioids